7d67d1f8a2d31971f4b650c0287f290b
Nalidixic Selective Supplement
MICROXPRESS – A DIVISION OF TULIP DIAGNOSTICS (P) LTD.·I·Ecuador ARCSA·Registered June 02, 2023
Device classification
- Risk class
- I
- Product type
- In Vitro Diagnostic
- Brand name
- MICROXPRESS; Accumix
- Commercial name
- 19-483 IVD Reagents/Kits, Microbiology, Bacteria, Culture Media
Registration information
- Analysis ID
- 7d67d1f8a2d31971f4b650c0287f290b
- Registration date
- June 02, 2023
- Expiration date
- June 02, 2028
Manufacturer
- Country
- INDIA
- Address
- PLOT NO. S-124, S-125, S-126, UTILITY PLOT NO. VIII, PHASE III-B, VERNA INDUSTRIAL ESTATE, VERNA, GOA - 403 722, INDIA.
Product owner
- Name
- MICROXPRESS – A DIVISION OF TULIP DIAGNOSTICS (P) LTD.
- Country
- INDIA
Authorized representative
- Address
- ORTEGA Y GASSETTE 09-64 Y PIO BOROJA
- Phone
- 32413285
Product use
CULTURE MEDIA AND SUPPLEMENTS FOR CLINICAL LABORATORY
About this record
Access comprehensive regulatory information for Nalidixic Selective Supplement in the Ecuador medical device market through Pure Global AI's free database. This I medical device is registered under ARCSA ID 7d67d1f8a2d31971f4b650c0287f290b and manufactured by MICROXPRESS – A DIVISION OF TULIP DIAGNOSTICS (P) LTD.. The device was registered on June 02, 2023.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.